BioSpace News Archive

Hospital for Special Surgery, the world’s leading academic medical center specialized in musculoskeletal health, and New Zealand-based medical device and technology company MARS Bioimaging Limited announced a new collaborative relationship based on MARS’s photon-counting spectral CT imaging technology.

The National Comprehensive Cancer Network® —an alliance of leading cancer centers—convened a policy summit to examine how geography impacts cancer outcomes.

CureDuchenne, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy, announced a collaborative clinical trial grant to test repurposing of the FDA-approved drug Vyvgart, for its potential ability to reduce antibodies to adeno-associated virus in Duchenne muscular dystrophy patients.

Galapagos NV announced the appointment of Thad Huston as Chief Financial Officer and Chief Operating Officer as per 1 July 2023.

ACELYRIN, INC. reported financial results for the first quarter ended March 31, 2023, and highlighted additional recent corporate achievements.

SELLAS Life Sciences Group, Inc. announced acceptance of an abstract for a poster presentation at the Annual Global Meeting of the International Gynecologic Cancer Society which will be held November 5-7, 2023, in Seoul, South Korea.

Novavax, Inc. participated in U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee’s meeting, which resulted in a unanimous vote recommending updating the current COVID vaccine composition to a monovalent XBB-lineage.

HUTCHMED Limited and Takeda announced that results of the Phase III FRESCO-2 study evaluating fruquintinib in patients with previously treated metastatic colorectal cancer were published in The Lancet.

Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced promising safety and efficacy data from a study of its off-the-shelf CD30.CAR EBVST therapy in patients with relapsed or refractory Hodgkin lymphoma.

Gemina Laboratories Ltd. is pleased to announce the company’s attendance at the American Association of Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo running from Sunday, July 23rd, 2023 to Thursday, July 27th, 2023 in Anaheim, California.